Andrew Retter is Chief Medical Officer of VOLITIONRX LTD. Currently has a direct ownership of 118,110 shares of VNRX, which is worth approximately $81,495. The most recent transaction as insider was on Sep 01, 2024, when has been sold 9,784 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 118K
9.03% 3M change
n/a 12M change
Total Value Held $81,495

Andrew Retter Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 01 2024
BUY
Grant, award, or other acquisition
-
9,784 Added 7.65%
118,110 Common Stock
Jun 01 2024
BUY
Grant, award, or other acquisition
-
8,326 Added 7.14%
108,326 Common Stock
May 23 2024
BUY
Grant, award, or other acquisition
-
100,000 Added 50.0%
100,000 Common Stock
AR

Andrew Retter

Chief Medical Officer
Henderson, NV

Track Institutional and Insider Activities on VNRX

Follow VOLITIONRX LTD and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VNRX shares.

Notify only if

Insider Trading

Get notified when an Volitionrx LTD insider buys or sells VNRX shares.

Notify only if

News

Receive news related to VOLITIONRX LTD

Track Activities on VNRX